🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomised, double-blind, placebo-controlled, crossover, single c...
Status
Completed
Location
Multiple Locations
Start Date
2011-09-22
Trial ID
NCT01432730
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of gefapix...
Status
Completed
Location
Center for Clinical Trials, LLC ( Site 0021)
Start Date
2020-05-10
Trial ID
NCT04193176
Treatments Being Tested
A randomized, double-blind, placebo-controlled, crossover, dose escalation ...
Status
Completed
Location
Multiple Locations
Start Date
2015-03-09
Trial ID
NCT02349425
Treatments Being Tested
This estimation study (no hypotheses) will evaluate the safety, tolerabilit...
Status
Completed
Location
Nagoya City University Hospital ( Site 3328)
Start Date
2018-03-16
Trial ID
NCT03482713
Treatments Being Tested
The purpose of this study is to assess the efficacy of gefapixant (AF-219/M...
Status
Terminated
Location
Afferent Investigative Site
Start Date
2012-04-13
Trial ID
NCT01569438
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
Cahaba Medical Care ( Site 0750)
Start Date
2018-09-11
Trial ID
NCT03654326
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of multi...
Status
Completed
Location
MD Clinical ( Site 0004)
Start Date
2019-04-10
Trial ID
NCT03882801
Treatments Being Tested
This is a randomized, double-blind, double-dummy, placebo-controlled, three...
Status
Completed
Location
Multiple Locations
Start Date
2013-12-16
Trial ID
NCT01993329
The purpose of this study is to evaluate the efficacy and safety of gefapix...
Status
Completed
Location
Pulmonary Associates, PA ( Site 0016)
Start Date
2020-05-21
Trial ID
NCT04193202
Treatments Being Tested
This was an 8-week randomized, parallel, double-blind, placebo-controlled s...
Status
Completed
Location
Afferent Investigative Site
Start Date
2015-12-17
Trial ID
NCT02612623
Treatments Being Tested